In the GLP1R gene, we found variants associated with dyslipidemia [82], resistance to liraglutide [83] and exenatide [84], metabolic syndrome [85], insulin levels [86], BMI [87], glucose levels [85,88], and obesity [89], according to previously studies. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.